Mobile

Otilonium Bromide in Irritable Bowel Syndrome – (OBIS) Double blind, randomized, parallel group, placebo-controlled study to evaluate the effect of otilonium bromide on abdominal pain and quality of l...

Mise à jour : Il y a 4 ans
Référence : EUCTR2005-001655-38

Otilonium Bromide in Irritable Bowel Syndrome – (OBIS) Double blind, randomized, parallel group, placebo-controlled study to evaluate the effect of otilonium bromide on abdominal pain and quality of life in patients with irritable bowel syndrome Barostat sub-study: Effect of otilonium bromide versus placebo on the perception of rectal distension in patients with irritable bowel syndrome (IBS)

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

Confirm efficacy of otilonium bromide for symptom control (frequency of abdominal pain in patients with irritable bowel syndrome (IBS) in a superiority trial versus placebo.

Critère d'inclusion

  • Irritable bowel syndrome

Liens